The effect of cold compression as the pain and bleeding in the area of Botulinum Toxin typeA injection for hemifacialspasm patients
Article Sidebar
Main Article Content
Abstract
Background: A 5-minutes cold compress can reduce pain during and after injection of Botulinum toxin type A, but the cold compress around the eye ball–where skin is very sensitive will cause a pain from the cold. The reduction of cold compress duration to 1-minute is reported to ease this pain and comfort the patients.
Objective: To study the duration effect of cold compresses on pain relief and reduction of bleeding at the injection area of botulinum toxin type A for hemifacialspasm patients.
Materials and methods: A double-blind, randomized controlled study of 28 hemifacialspasm patients with administrated at the spastic clinic Buddhasothorn Hospital. The 28 patients were randomly divided into 2 groups : the experimental group received a 1-minute cold compress prior to the botulinum toxin type A injection and secondly the control group received a 5-minutes cold compress before the injection.
Results: The experimental group and the control group had the pain score 3.3±1.5 and 2.8±1.8. Bleeding at the injection site was 14.3% and 7.1% which was no statistical differences (p = 0.43, p = 1)
Conclusions: A 1-minute and 5-minutes cold compress prior of Botulinum toxin type A injection for hemifacialspasm patients had not statistical differences in decreasing pain (NRS) and bleeding at injection site.
Article Details
References
Suputtitada A. Clinical use of botulinum toxin. J Thai Rahabili Med 2012; 22: 38-41.
Simpson DM, Blitzer A, Brashear A, Camilla C, Dubinsky R, Haslett M, et al. Assessment: botulinum neurotoxin for the treatment of movement disorders (an evidence-based review): report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology. Neurology 2008; 70:1699-706.
Saeliw P, Preechawai P, Aui-aree N. Evaluating the effects of ice application on patient comfort before and after botulinum toxin type a injections. J Med Assoc Thailand 2010; 93:1200-4.
Sarifakioglu N, Sarifakioglu E. Evaluating the effect s of ice application on the pain felt during botulinum toxin type-a injections: a prospective, randomized, single-blind controlled trial. Ann Plast Surg 2004; 53: 543-6.
Weber DC, Hoppe KM. Physical agent modalities. In: Braddom RL, Chan L, Harrast MA, Kowalske KJ, Matthews DJ, Ragnarsson KT, et al. editors. Physical Medicine and Rehabilitation. 4thed. Philadelphia: Elsevier Saunders; 2011. p. 449-65.
Linder JS, Edmonson BC, Laquis SJ, Drewry RD Jr, Fleming JC. Skin cooling before periocular botulinum toxin a injection. Ophthalmic Plast Reconstr Surg 2002;18:441-2.
Naowapanich S, Fooseang W, Kheawklee L, Robkob H, Ouangian PT. Randomized controlled trial of cold application on the occurrence of bruise, hematoma and pain at the injection site of subcutaneous low molecular weight heparin. Siriraj Nursing Journal. 2008;2(2):14-23.
Pituksung A, Chirapapaisan N, Konlakij D, Suratako R, Kumteam K. The effect of cold compression as the pain relieving for botulinum toxin A injection for the blepharospasm patients. J Nurs Sci 2015;33(2) 61-7.
Kim EJ, Buschmann MT. Reliability and validity of the faces pain scale with older adults. Int J Nurs Stud 2006; 43: 447-56.